Summary
Theranos, Inc. (Theranos) is a medical device and healthcare company that develops automated and personalized monitoring systems. The company’s technology product can perform lab tests on samples blood draw. It provides detection and prevention of disease, and empower people. Theranos offers products control and micro-processes offering tests with high levels of precision. The company has also automated pre- and post-analytic processes, minimizing human processing, and reducing the cause of lab-test errors. It provides test analysis for Bblood typing, acetaminophen, ammonia, basic metabolic panel, cholesterol, creatine kinase, digoxin and epstein-barr antibody, among others. Theranos is headquartered in Palo Alto, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Theranos, Inc.
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table Of Contents
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Theranos, Inc. Company Snapshot 5
Theranos, Inc. Company Overview 5
Theranos, Inc. Pipeline Products and Clinical Trials Overview 6
Theranos, Inc. – Pipeline Analysis Overview 8
Key Facts 8
Theranos, Inc. - Major Products and Services 9
Theranos, Inc. Pipeline Products by Development Stage 10
Theranos, Inc. Pipeline Products Overview 12
Ebola Blood Test 12
Ebola Blood Test Product Overview 12
HSV-1 IgG Test - Capillary Plasma 13
HSV-1 IgG Test - Capillary Plasma Product Overview 13
HSV-1 IgG Test - Capillary Whole Blood 14
HSV-1 IgG Test - Capillary Whole Blood Product Overview 14
HSV-1 IgG Test - Venous Plasma 15
HSV-1 IgG Test - Venous Plasma Product Overview 15
HSV-1 IgG Test - Venous Serum 16
HSV-1 IgG Test - Venous Serum Product Overview 16
Theranos, Inc. - Key Competitors 17
Theranos, Inc. - Key Employees 18
Theranos, Inc. - Locations And Subsidiaries 19
Head Office 19
Recent Developments 20
Theranos, Inc., Recent Developments 20
Jul 07, 2016: Theranos Receives Notice of Sanctions from the Centers for Medicare & Medicaid Services 20
May 11, 2016: Theranos Announces Expansion of Board of Directors and New Organizational Structure 20
Apr 07, 2016: Theranos Announces Leading Medical and Laboratory Experts Join Scientific and Medical Advisory Board 21
Oct 28, 2015: Statement from Theranos 23
Sep 28, 2015: Theranos Named 2015 Arizona Bioscience Company of the Year 24
Aug 24, 2015: Practice Fusion Surpasses 600th Partnership Deal Becoming the Most Integrated Cloud-Based EHR Platform 25
Jul 15, 2015: First-of-its-Kind Partnership between Theranos and AmeriHealth Caritas to Improve Health Care for the Underserved 25
Jul 08, 2015: Theranos and Capital BlueCross Team Up to Provide Innovative, Low Cost, Accessible Lab Testing Services in Central Pennsylvania 26
Jul 02, 2015: FDA Clears Theranos’s Herpes Simplex 1 Virus IgG Test 27
Mar 09, 2015: Theranos and Cleveland Clinic Announce Strategic Alliance to Improve Patient Care through Innovation in Laboratory Testing 27
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29
List Of Tables
List of Tables
Theranos, Inc. Pipeline Products and Clinical Trials Overview 6
Theranos, Inc. Pipeline Products by Equipment Type 6
Theranos, Inc. Pipeline Products by Indication 7
Theranos, Inc., Key Facts 8
Theranos, Inc., Major Products and Services 9
Theranos, Inc. Number of Pipeline Products by Development Stage 10
Theranos, Inc. Pipeline Products Summary by Development Stage 11
Ebola Blood Test - Product Status 12
Ebola Blood Test - Product Description 12
HSV-1 IgG Test - Capillary Plasma - Product Status 13
HSV-1 IgG Test - Capillary Plasma - Product Description 13
HSV-1 IgG Test - Capillary Whole Blood - Product Status 14
HSV-1 IgG Test - Capillary Whole Blood - Product Description 14
HSV-1 IgG Test - Venous Plasma - Product Status 15
HSV-1 IgG Test - Venous Plasma - Product Description 15
HSV-1 IgG Test - Venous Serum - Product Status 16
HSV-1 IgG Test - Venous Serum - Product Description 16
Theranos, Inc., Key Employees 18
Lisst Of Figures
List of Figures
Theranos, Inc. Pipeline Products by Equipment Type 7
Theranos, Inc. Pipeline Products by Development Stage 10
